Neurizon Therapeutics Limited (ASX:NUZ)
Australia · Delayed Price · Currency is AUD 0.0760
-0.0020 (-2.56%)
Sep 11, 2026, 10:54 AM AEST
Neurizon Therapeutics Market Cap
Neurizon Therapeutics has a market cap or net worth of 60.46 million as of September 10, 2026. Its market cap has decreased by -15.31% in one year.
Market Cap
60.46M
Enterprise Value
51.06M
Revenue
17.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
ChartMarket Cap Chart
Since September 12, 2002, Neurizon Therapeutics's market cap has increased from 4.18M to 60.46M, an increase of 1,345.25%. That is a compound annual growth rate of 11.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 60.46M | 32.75% |
| Dec 31, 2025 | 45.54M | -45.58% |
| Dec 31, 2024 | 83.69M | 94.55% |
| Dec 29, 2023 | 43.02M | 112.09% |
| Dec 30, 2022 | 20.28M | -36.00% |
| Dec 31, 2021 | 31.69M | -4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LTR Pharma | 92.71M |
| Arovella Therapeutics | 76.16M |
| Avecho Biotechnology | 73.41M |
| Prescient Therapeutics | 71.50M |
| Entropy Neurodynamics | 68.57M |
| Immutep | 67.79M |
| Amplia Therapeutics | 66.73M |
| Botanix Pharmaceuticals | 57.47M |